PSUSA/00010355/202409
PSUSA/00010355/202409
PSUSA/00010355/202409
ADRA project - information session for veterinary pharmaceutical industry, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2025, 14:30 (CEST) to 22 May 2025, 16:00 (CEST)
Floseal haemostatic matrix (Floseal VH S/D) - Procedural steps and scientific information after initial consultation (archive)
EMEA-003063-PIP03-22
Human medicines European public assessment report (EPAR): Cinainu, dry aqueous extract of paullinia cupana seed,dry hydroethanolic extract of theobroma cacao seed,liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Ovitrelle, choriogonadotropin alfa, Date of authorisation: 02/02/2001, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised
Timetable: Type II variation and worksharing application alternative monthly assessment
Timetable: Type II variation and worksharing application weekly assessment
Human medicines European public assessment report (EPAR): Komboglyze, saxagliptin,metformin hydrochloride, Date of authorisation: 24/11/2011, Revision: 23, Status: Authorised